Biologic treatments are a new option for people with moderate to severe eczema or atopic dermatitis. Most people can control eczema with prevention techniques, topical treatments, or ultraviolet ...

Dupilumab (Dupixent) is a biologic approved for people ages 6 months and older, if your atopic dermatitis cannot be controlled with topical creams. You need a prescription to get it.

If you have atopic dermatitis, a skin condition commonly known as eczema, prescription creams or other topical medicines and moisturizers are usually enough to manage it.However, if your eczema is ...

A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates that initiating ruxolitinib cream therapy for atopic ...

People with moderate-to-severe atopic dermatitis, the most common form of eczema, don’t always get adequate relief from topical treatments like steroid creams and ointments.

Tralokinumab-ldrm (Adbry) is another biologic that is FDA approved for adults and children 12 years of age and older with moderate to severe atopic dermatitis that can’t be adequately controlled ...

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

Real-world treatments for patients with dermatologic conditions like psoriasis and atopic dermatitis were analyzed based on their abilities to decrease severity while remaining cost effective. 1,2 ...

Atopic dermatitis, a chronic inflammatory skin rash, affects about 20% of children and 10% of adults, said Dr. Elizabeth Muennich, president and CEO of Dermatology and Skin Care Associates.

Zoryve (roflumilast) cream 0.15% is now available for the topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 6 years of age and older.